2.SCREENING OF PROBIOTIC LACTOBACILLUS AND THEIR CHARACTERISTIC
Hui-Ming YU ; Yong LIN ;
Microbiology 1992;0(01):-
According to the requirements of ptobiotics, we have separated 13 strains of Lactobacillus from the content in gut of lactating piglet. Among them 3strains are L. acidophilus, one is L. casei, one is L. atenaforme and 8 strains are L. fermentum. They can resist 1.0% bile salt and the acidity of pH3.0, can inhibit pathogenic Escherichia coli and Staphylococcus aureus. They are safe and non-toxic to mice.
3.Limb-shaking transient ischemic attack responsive to nimodipine: A case report
Liang-Yong Li ; Chuan-Yong Yu ; Lin Huang ; Yu Wang
Neurology Asia 2012;17(4):353-356
Limb-shaking transient ischemic attack (TIA), a rare manifestation, is commonly caused by severe
stenosis or occlusion of an extracranial internal carotid artery. Such patients are usually treated with
surgical revascularization or anti-platelet therapy. We present a 56-year-old woman with 6 months’
episodic attacks starting with mouth skewed to the right and a sensation of ‘weakness’ involving
predominantly her left arm, and at times, also involved the left leg. This was immediately followed by
rhythmic jerky movements of the left arm and at times, also involved the left leg. Magnetic resonance
angiography revealed severe stenosis of M1 segment of the right middle cerebral artery. The patient’s
symptoms were signifi cantly improved by treatment with anti-platelet drugs and nimodipine.
4.Effect of cytochrome P450 2C19 genotypic polymorphism on treatment efficacy for gastroesophageal reflux disease by rabeprazole
Jiandong YU ; Yong LIN ; Zonghai REN ; Tingting JI
Chinese Journal of Primary Medicine and Pharmacy 2017;24(15):2260-2263
Objective To investigate whether the effect of rabeprazole in treating gastroesophageal reflux disease is related to CYP2C19 gene polymorphisms.Methods 278 patients with gastroesophageal reflux disease confirmed by endoscopy and proton-pump inhibitor testing were enrolled in this study,including non erosive reflux disease (NERD) in 122 cases,the reflux esophagitis (RE) in 98 cases and Barrett esophagus in 58 cases.They were treated with rabeprazole for 8 weeks.GerdQ scores before and after the treatment were completed,endoscopy was performed again in patients with RE after treatment.The blood CYP2C19 genotyping was detected by matrix assisted laser desorption ionization time of flight mass spectrum(MALDI-TOF-MS).Results According to the genotype of CYP2C19,they were divided into extensive metabolizers,intermediate metabolizers and poor metabolizers,accounted for 39.57%,42.45% and 17.98%,respectively.There was no significant difference in GerdQ scores of three groups before treatment,and also had no significant difference after 8 weeks treatment,but in each subgroup GerdQ scores after treatment was decreased significantly than before treatment.The total effective rate of 98 patients with RE by endoscopy was 86.73%,but there was no significant difference in total effective rate of the three groups after treatment.Conclusion Rabeprazole is effective in the treatment of gastroesophageal reflux disease.Moreover,rabeprazole is less affected by CYP2C19 genotype and therefore its curative effect is more stable.
5.Progress in pharmacological effects and clinical applications of berberine
Yu XING ; Xin LIU ; Yuan LIN ; Yong ZHANG
Chinese Journal of Pharmacology and Toxicology 2017;31(6):491-502
Berberine is an isoquinoline alkaloid isolated from Rhizoma Coptidis and Cortex Phellodendri,which has a long medical history in China.Recent studies have indicated that berberine has multiple pharmacological activities including anti-inflammatory,anti-microorganisms,anti-cancer,cardiac protection,glucose lowering,regulating lipid metabolism and immune suppression.Berberine has been used for the treatment of intestinal infectious diseases for many years.With the continuous progress of the research,it is reported that berberine has many new clinical applications,including treatment of the cardiovascular disease,metabolic syndrome and its complications,cancers,abdominal adhesions and chlamydia trachomatis infection.This review is intended to introduce the role of berberine in various aspects of pharmacological effects,molecular mechanisms and clinical applications.
6.Embedding catgut acupoint and blood-letting at trigger point for 58 cases of primary trigeminal neuralgia.
Hong-Yan HAN ; Yong-Qing LIN ; Pei-Yu WANG
Chinese Acupuncture & Moxibustion 2012;32(7):591-592
Acupuncture Points
;
Acupuncture Therapy
;
methods
;
Adult
;
Aged
;
Catgut
;
Female
;
Humans
;
Male
;
Middle Aged
;
Phlebotomy
;
Trigeminal Neuralgia
;
therapy
7.Effect of RNA DcR3 interference on the proliferation of ovarian cancer cell CAOV3
Jingxian LIN ; Yong PENG ; Guifang YU ; Qiong ZENG ; Ting ZHONG
The Journal of Practical Medicine 2015;31(16):2601-2604
Objective To investigate the effects of siRNA targeting decoy receptor 3 on the cell proliferation of ovarian carcinoma cell CAOV3. Methods We constructed siRNA targeting decoy receptor 3,which was transfected into ovarian carcinoma cells CAOV3 , and observed the effects of DcR3 siRNA on the cell proliferation of CAOV3 cell by MTT experiment. The experiment contained 3 groups, including the normal control group (CAOV3 cell was not transfected), the negative control group (CAOV3 cell was transfected with blank vector) and the experimental group (CAOV3 cell was transfected with DcR3 siRNA). The expression levels of DcR3 mRNA were detected by Real-time PCR. Results DcR3 siRNA recognized and degraded DcR3 mRNA in CAOV3 cells of the experimental group. DcR3 mRNA of the experimental group was significantly decreased. The proliferation of CAOV3 cell was significantly decreased by DcR3 siRNA comparing with the normal control group and negative control group (P < 0.01). Conclusion DcR3 siRNA can inhibit the proliferation of ovarian cancer cell line CAOV3 by recognized and degraded DcR3 mRNA.
9.Unrelated umbilical cord blood stem cell transplantation in a patient with chronic myelocytic leukemia.
Yu-deng LIN ; Yi-kui SHEN ; Yong-kang LI
Chinese Journal of Pediatrics 2006;44(8):586-586
Blood Donors
;
Child
;
Cord Blood Stem Cell Transplantation
;
adverse effects
;
methods
;
Female
;
Follow-Up Studies
;
Graft vs Host Disease
;
prevention & control
;
Humans
;
Infant, Newborn
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
surgery
;
Transplantation, Homologous
;
Treatment Outcome
10.Treatment with antisense Smad2 oligodeoxynudeotides reduces extracellular matrix secretion in rat mesangial cells cultured with high glucose
Shengqiang YU ; Lingyun LAI ; Ji MA ; Yong GU ; Shanyan LIN
Chinese Journal of Nephrology 1994;0(02):-
Objective To investigate the effects of antisense Smad2 oligodeoxynudeotides(ODN) on fibronetin(FN) and collagen Ⅳ(ColⅣ) secretion of rat mesangial cells cultured with high glucose, explore the action of Smad2 in the glomerulosclerosis and to find a new method to retard the progress of glomerular fibrosis. Methods 20-mer antisense, sense and random ODNs were designed and synthesized that were phosphorothioate modified to increase stability. The antisense ODN encompassed the ATG of the rat Smad2 gene. ODN was tranferred transiently into rat mesangial cells through liposome. Rat cells were treated with high glucose. mRNA and protein of Smad2 were detected by RT-PCR and cytochemistry. FN and ColⅣ were examined by ELISA. Results Antisense ODN significantly decreased mRNA and protein expression of Smad2 in rat mesangial cells treated with high glucose(P